US FDA’s New Drug Median Review Time Held Steady At Eight Months In 2021

 
• By Bridget Silverman
  
FDA review times are track.
FDA continues to speed through novel drug reviews. • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers